Cioffi Melina 4
4 · Aquestive Therapeutics, Inc. · Filed Mar 11, 2026
Research Summary
AI-generated summary of this filing
Aquestive (AQST) SVP Melina Cioffi Sells Shares, Receives Awards
What Happened Melina Cioffi, Senior Vice President of Regulatory Affairs at Aquestive Therapeutics (AQST), executed a sell-to-cover transaction and received equity awards. On 2026-03-10 she sold 25,311 shares in open-market trades for a weighted average price of $4.17, generating $105,623. On 2026-03-09 she was granted 100,000 restricted shares (acquired at $0) and a 75,000-share derivative award reported at $4.29 per share (value $321,750).
Key Details
- Transaction dates: awards granted 2026-03-09; sale executed 2026-03-10; Form 4 filed 2026-03-11.
- Sale price(s): weighted average $4.17; sale executed in multiple trades at $4.17–$4.32 (per footnote).
- Award values: 100,000 restricted stock units/shares reported at $0 (restricted stock); 75,000 derivative shares reported at $4.29 ($321,750).
- Vesting: both the restricted stock and the derivative awards/options vest over three annual installments (25% / 25% / 50%) per footnotes F1 and F4.
- Tax withholding/sell-to-cover: the 25,311-share sale was to satisfy tax withholding on vesting (footnote F2) and is not a discretionary sale by the reporting person.
- Shares owned after the transactions: not specified in the provided filing excerpt.
- Filing timeliness: filed on 2026-03-11 for transactions through 2026-03-10; no late filing indicated.
Context
- The sale was a mandatory sell-to-cover tied to tax withholding on equity awards and therefore does not necessarily indicate a personal decision to reduce holdings.
- The 75,000 “derivative” award is subject to vesting (per footnote) rather than an immediate free-and-clear transfer of shares.
Insider Transaction Report
Form 4
Cioffi Melina
SVP, Regulatory Affairs
Transactions
- Award
Common Stock
[F1]2026-03-09+100,000→ 300,178 total - Sale
Common Stock
[F2][F3]2026-03-10$4.17/sh−25,311$105,623→ 274,867 total - Award
Non-Qualified Stock Option (right to buy)
[F4]2026-03-09$4.29/sh+75,000$321,750→ 75,000 totalExercise: $4.29Exp: 2036-03-09→ Common Stock (75,000 underlying)
Footnotes (4)
- [F1]The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F3]This transaction was executed in multiple trades at prices ranging from $4.17 to $4.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
Signature
/s/ Lori Braender, as Attorney-In-Fact|2026-03-11